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Abstract
To assess the level of intra-patient diversity and evolution of HIV-1C non-structural genes in primary infection, viral
quasispecies obtained by single genome amplification (SGA) at multiple sampling timepoints up to 500 days post-
seroconversion (p/s) were analyzed. The mean intra-patient diversity was 0.11% (95% CI; 0.02 to 0.20) for vif, 0.23% (95% CI;
0.08 to 0.38) for vpr, 0.35% (95% CI; 20.05 to 0.75) for vpu, 0.18% (95% CI; 0.01 to 0.35) for tat exon 1 and 0.30% (95% CI; 0.02
to 0.58) for rev exon 1 during the time period 0 to 90 days p/s. The intra-patient diversity increased gradually in all non-
structural genes over the first year of HIV-1 infection, which was evident from the vif mean intra-patient diversity of 0.46%
(95% CI; 0.28 to 0.64), vpr 0.44% (95% CI; 0.24 to 0.64), vpu 0.84% (95% CI; 0.55 to 1.13), tat exon 1 0.35% (95% CI; 0.14 to
0.56 ) and rev exon 1 0.42% (95% CI; 0.18 to 0.66) during the time period of 181 to 500 days p/s. There was a statistically
significant increase in viral diversity for vif (p=0.013) and vpu (p=0.002). No associations between levels of viral diversity
within the non-structural genes and HIV-1 RNA load during primary infection were found. The study details the dynamics of
the non-structural viral genes during the early stages of HIV-1C infection.
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Introduction
The majority of HIV infections in the world, specifically those in
sub-Saharan Africa, are attributable to subtype C cementing its
status as a major public health concern. Insights into the primary
phase of HIV-1C infection are important to better understand
disease pathogenesis and early mechanisms of virus-host interac-
tions affecting disease progression. A recent study showed that
mutational patterns during the first 5 weeks of infection in
a subtype B cohort indicated rapid viral population growth and
included a slight decrease in viral genetic diversity over the first 20
to 40 days [1]. Numerous studies have linked viral diversity in
HIV-1 structural genes with disease progression [2–8]. However,
little is known about the diversity and evolution of non-structural
genes, which are crucial for virus replication particularly during
the early stages of the virus life cycle.
To our best knowledge no published reports to date have
pertained to diversity and/or divergence of viral non-structural
genes during primary HIV-1 subtype C infection. Salazar-
Gonzales et al. showed that the transmitted/founder full length
sequences from 12 subjects (9 infected with HIV subtype B and 3
subtype C) contained intact non-structural genes [9]. Michael et
al. reported defective accessory genes (HXB2 sequence positions
4,961 to 6,346) in longitudinal HIV-1 subtype B infection [10]. A
study on evolution of HIV-1 subtype B Tat and Rev demonstrated
that viral mutations were identified within the predicted CTL
epitopes suggesting that CTL-mediated selection plays an impor-
tant role in viral escape from immune pressure and early viral
evolution [11]. A longitudinal study on twins infected with HIV-1
subtype B perinatally showed discordant disease progression rates
with a dramatic increase in tat gene sequence diversity in the sicker
child over time [12].
Associations between long term non-progression and viral
mutations (including deletions) in HIV-1 non-structural genes
have been reported previously [13–19]. Yedavalli et al. found that
HIV-1 Vif and Vpr were less conserved in their functional
domains in a cohort of HIV-1 non-transmitting mothers [20].
A systematic approach to assess the evolution of HIV-1 non-
structural genes during primary infection is critical to better
understand the role these genes play in HIV-1 pathogenesis and
their potential association with early disease progression. This
seems particularly important for HIV-1C where a significant
fraction of early infections have shown extended periods of high
viral RNA load and rapid progression to loss of CD4 lymphocyte
numbers and disease progression [21,22]. This knowledge could
inform HIV vaccine design as non-structural viral genes are
potentially attractive vaccine candidates. The increased levels of
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e35491viral replication in HIV-infected individuals rapidly progressing to
AIDS can result in greater virus diversity. Although HIV-1 non-
structural genes are thought to be relatively conserved, the extent
of conservation has been understudied. In this study we assess viral
diversity and evolution of five major non-structural HIV-1 genes
vif, vpr, vpu, tat exon 1 and rev exon 1 during the primary phase of
HIV-1 subtype C infection up to 500 days post-seroconversion (p/
s). We addressed the following questions: (1) What are the
phylogenetic relationships of HIV-1 nonstructural genes during
primary HIV-1 infection? (2) What is the level of intra-patient
diversity during primary infection? (3) How does viral diversity in
non-structural HIV-1 genes change over time? and (4) Is HIV-1
RNA load in plasma associated with diversity of HIV-1 non-
structural genes during primary HIV-1 infection?
Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki, and was approved by the Human
Research Development Committee of the Botswana Ministry of
Health and by the Office of Human Research Administration at
the Harvard School of Public Health. All study participants
provided written informed consent for the collection of samples
and subsequent analysis.
Study Subjects
Study subjects were enrolled in the primary HIV-1C infection
cohort in Botswana and followed-up during 2004–2010 [23]. A
subset of 20 adults (eight acutely infected individuals and 12
randomly selected seroconverters) included 5 males and 15 females
(Table S1). Age of subjects at enrollment ranged from 20 to 53
years. Acutely infected subjects (patient code A through H) were
identified before seroconversion within Fiebig stage II [24] by
a negative HIV-1 serology combined with a positive HIV-1 RT-
PCR test. Twelve seroconverters (two-digit patient code OC to
QR) were identified within the early stage of HIV-1 infection and
included 3 subjects within Fiebig stage IV, 4 subjects within Fiebig
stage V, 2 subjects on the edge of Fiebig stage V and VI, and 3
subjects in Fiebig stage VI. The time of seroconversion (time 0)
was estimated as the midpoint between the last seronegative test
and the first seropositive test (approximately one week in most
cases) for the acutely infected subjects and by mid-point of the
corresponding Fiebig stage for the recently infected subjects [23].
Written informed consent was obtained from all study partici-
pants; ethical approval for this research was obtained from the
Human Research Development Committee of the Botswana
Ministry of Health and OHRA at Harvard School of Public
Health.
Viral RNA Extraction and cDNA Synthesis
Viral RNA was isolated from plasma by QIAamp viral RNA
Mini kit (Qiagen, Valencia, CA) according to the manufacturer’s
instructions. For viral loads .35,000 copies/ml viral RNA was
isolated from 140 ml of plasma, for samples with viral loads
,35,000 copies per ml, a volume of plasma containing 5,000 viral
RNA copies was spun down at 24,0006g at 4 degrees for 1 hour,
the supernatant was removed, the pellet was re-suspended in
140 ml of supernatant for RNA extraction. For samples with viral
loads ,5,000 copies per ml, the entire aliquot (1.5 mL) was spun
down and the pellet was re-suspended in 140 ml of supernatant
followed by RNA extraction. Viral RNA was recovered from spin
columns in an elution volume of 60 ml. Reverse transcription to
single-stranded cDNA was performed using SuperScript III
(Invitrogen, Carlsbad, CA) according to manufacturer’s instruc-
tions and primer OFM19 (59 –GCA CTC AAG GCA AGC TTT
GAG GCT TA - 39; HXB2 coordinates 9632 to 9604).
Single Genome Amplification (SGA) and Sequencing
The single genome amplification was based on the method of
limiting dilutions [25], and was used with minor modifications. A
median (IQR) of 2.5 (2 to 4) timepoints were sequenced for each
patient, and a median of 11.5 (10.4 to 13.5) sequences were
generated per patient. The median (IQR) time range of sampling
post-seroconversion was 174 (55–349) days. Briefly, the cDNA
produced was diluted in 96 well plates with the aim to yield ,30%
positive reactions of PCR-amplified product. The targeted region
spanned from HXB2 nt position 5,041 to 6,310, and included
HIV-1 sequence encoding overlapping non-structural viral genes
vif (nt positions 5,041 to 5,619; HXB2 numbering), vpr (nt positions
5,559 to 5,850), tat exon1 (nt positions 5,831 to 6,045), rev exon 1
(nt positions 5,970 to 6,045) and vpu (nt positions 6,062 to 6,310).
The diluted cDNA corresponding to about 30% of positive PCR
was used as a template for two rounds of nested PCR. The first
round PCR was conducted using primers Vif1bw- 59 – GGG TTT
ATT ACA GAG ACA GCA GAG- 39 (HXB2 coordinates 4900 to
4923) and OFM19, and second-round PCR primers Fvif- 59 -
AGA CCC TAT TTG GAA AGG ACC AGC - 39 (HXB2
coordinates 4922 to 4945) and Rvpu- 59-CTT CTT TCC ACA
CAG GTA CCC CAT- 39 (HXB2 coordinates 6366 to 6343). The
amplicons were sequenced on both strands. Sequencing primers
included Rvpu, Fvif, 5198L- 59 - TCC AGG GCT CTA GGT
TAG - 39, 4679L- 59 - GCC CAG GGT CTA CTT GTG - 39;a n
additional primer 1466L- 59 - TCA TTG CCA CTG TCT TCT
GCT CTT - 39 was used to increase coverage in cases primer
5198L failed. Amplicons were Exo-SAP purified [26], and
sequenced directly using BigDye technology on the ABI 3730
DNA Analyzer. The sequence fragments were assembled and
edited using SeqScape v2.6 (Applied Biosystems). The sequences
generated were tested using HYPERMUT v 2.0 [27], and all
hypermutated sequences were excluded from the analysis. A total
of 6 out of 667 (0.88%) sequences were found to be hypermutated.
During the preliminary analysis of viral quasispecies a link was
identified between sequences of subjects OI and OK. We ruled out
a potential contamination by (1) similar clustering patterns
observed in structural genes, env and gag, of the same subjects
(env/gag unpublished data from same cohort); (2) similar branching
topology of viral sequences obtained at multiple timepoints of
sampling; (3) nucleic acid isolation, PCR amplification and
sequencing were separated by place and time; and (4) proper
quality controls were used in each experiment.
HIV-1 Subtyping
Nucleotide sequences were codon aligned using the MUSCLE
algorithm implemented in Mega 5 [28] followed by manual
adjustment in Bioedit [29]. For HIV-1 subtyping, three sequences
per patient were randomly selected from the pool of generated
viral quasispecies. The selection criteria included earliest timepoint
available and sequence length with more than 90% coverage of
the targeted region (5,041 to 6,310 nt position in HXB2). To
determine phylogenetic relationships and clustering patterns of
generated viral sequences, the phylogenetic tree reconstruction
was performed using Neighbor joining, Maximum likelihood, and
Bayesian methods. A standard set of HIV-1 subtype references
from LANL was included in the analysis. The sequence
CPZ.CM.98.CAM3.AF115393 was used as an outgroup. The
online Rega-2 subtyping tool was used in parallel for confirmation
[30].
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The intra-patient mean pairwise distances were measured in
Mega 5 using the Maximum Composite Likelihood (MCL) model,
following nucleotide sequences alignment using the MUSCLE
algorithm implemented in Mega 5 [28] and manual adjustment in
Bioedit [29]. Mean values were calculated at each sampling
timepoint and the averages of these were used in each time ‘‘bin’’
(0–90, 91–180, 181–500 days p/s). The viral diversity for each
non-structural gene was computed as a mean value with 95%
Confidence Interval (CI). HIV-1 RNA load in plasma was
measured routinely at each study visit over the first year of
follow-up. The study schedule included weekly visits for the first
two months, bi-weekly for the next two months, and monthly for
the next eight months for acutely infected individuals, or monthly
for individuals identified within Fiebig stage IV-V. After the first
year, quarterly study visits were scheduled for all subjects. Details
of HIV-1 RNA load measurement have been presented elsewhere
[21,22,31]. Mean values for the analyzed time intervals, 0–90 days
p/s, 91–180 days p/s, and 181–500 days p/s, and for 100–300
days p/s as described previously, were also included [21]. Potential
associations between intra-patient viral diversity and HIV-1 RNA
load at the three time intervals, 0–90 days p/s, 91–180 days p/s,
and 181–500 days p/s, were assessed.
Statistical Methods
Sigma plot version 11 was used for descriptive statistics to
summarize medians, means, and standard deviations. Compar-
isons between groups were made using t-test and Mann Whitney
Rank sum test for continuous and binary outcomes respectively.
All reported p-values are 2-sided. Regression analysis was
performed using linear regression and the Spearman Rank Test.
GenBank Accession Numbers
Sequences have been assigned GenBank accession numbers
JQ895561–JQ896230.
Results
Inferred Phylogeny of Non-structural Viral Sequences
All generated sequences in this study clustered with HIV-1
subtype C reference sequences (Fig. 1). The subject-specific splits
were supported by branching topology and clade credibility values
of $0.99 in the Bayesian analysis. One epidemiologically linked
pair, subjects OI and OK, was identified; contamination of
samples from subjects OI/OK pair was ruled out.
Good congruence and similar branching topology was observed
between the Bayesian (Fig. 1), maximum likelihood (ML; Fig. S1),
and neighbor joining (NJ; Fig. S2) tree reconstruction methods.
The reliability of the branching topology and clustering patterns
was supported by both the approximate likelihood ratio test
(aLRT) for ML tree of $0.99 and the bootstrap (1,000 replicates)
estimates of $99% in the NJ analysis. The observed splits support
and phylogenetic relationships suggest that the HIV-1 non-
structural gene region comprised of vif, vpr, vpu, tat exon 1 and
rev exon 1 can be used reliably for HIV-1 subtyping. The HIV-1
subtyping results were congruent with results obtained using the
Rega-2 HIV-1 subtyping tool (data not shown).
To address whether phylogeny of non-structural genes is
consistent with multiplicity of HIV-1 transmission, the branching
topology of generated viral quasispecies at early timepoints (0–90
days p/s) were analyzed and compared with branching patterns
with HIV-1C structural genes, env and gag [32]. The inferred
phylogeny in 3 (15%) subjects included in this study supported
transmission of multiple viral variants, and was consistent with our
previous findings in env/gag analysis (Fig. 2). For example, more
diversified branching topology was observed in subject D (env/gag:
transmission of multiple viral variants) compared to subject B (env/
gag: transmission of single viral variant).
Intra-patient Diversity and Diversification of HIV-1C Non-
structural Genes During Primary Infection
To assess the level of intra-patient diversity of HIV-1C non-
structural genes in primary infection, we used viral quasispecies
obtained by SGA at multiple sampling timepoints from serocon-
version up to 500 days p/s. The mean intra-patient diversity was
0.11% (95% CI; 0.02 to 0.20) for vif, 0.23% (95% CI; 0.08 to 0.38)
for vpr, 0.35% (95% CI; 20.05 to 0.75) for vpu, 0.18% (95% CI;
0.01 to 0.35) for tat exon 1 and 0.30% (95% CI; 0.02 to 0.58) for
rev exon 1 during the time period 0 to 90 days p/s. The intra-
patient diversity increased gradually in all non-structural genes
(Fig. 3), which was evident from the vif mean intra-patient diversity
of 0.46% (95% CI; 0.28 to 0.64), vpr 0.44% (95% CI; 0.24 to 0.64),
vpu 0.84% (95% CI; 0.55 to 1.13), tat exon 1 0.35% (95% CI; 0.14
to 0.56) and 0.42% (95% CI; 0.18 to 0.66) for rev exon 1 during the
time period of 181 to 500 days p/s. There was a significant
increase in viral diversity calculated using the Mann-Whitney
Rank Sum Test for vif (p=0.013) and vpu (p=0.002).
The intra-patient viral diversity of HIV-1C non-structural genes
suggested a high level of conservation during primary infection
(Fig. 4). A tight range of viral diversity was observed for each non-
structural gene analyzed, at the earliest timepoint (0–90 days p/s):
vif (0%–0.51%), vpr (0%–0.58%), vpu (0%–1.98%), tat exon 1 (0%–
0.86%) and rev exon 1 (0%–1.33%). At later timepoints, over the
first year of HIV1-C infection, an increase was also observed, the
range of viral diversity was tight: vif (0%–1.11%), vpr (0%–1.30%),
vpu (0.28%–2.35%), tat exon 1 (0%–1.66%) and rev exon 1 (0%–
1.57%). To assess the change in diversity over time, slopes of
changes were analyzed. The gradual increase observed by positive
slopes of viral diversity (vif, 0.40%; vpr; 0.25%; vpu, 0.61%; tat
exon1, 0.19%; and rev exon1, 0.05%) is consistent with ongoing
viral evolution.
HIV-1 RNA Load and Diversity within HIV-1C Non-
structural Genes
The potential association between intra-patient non-structural
gene diversity and levels of viral RNA load during primary HIV-
1C infection was examined. It was assumed that higher levels of
viral replication during the early stages of infection could drive
increased viral diversity at later timepoints. The levels of intra-
patient diversity within vpr and HIV-1C RNA load at 0–90 days
p/s showed a weak but statistically significant correlation
(r
2=0.587, p=0.042). The intra-patient diversity within tat exon
1 and rev exon 1 at later timepoints (181–500 days p/s) was
associated with HIV-1 RNA load at the baseline timepoint,
r
2=0.505, p=0.044; and r
2=0.577, p=0.019, respectively.
There was association between tat exon 1 diversity and HIV-1
RNA load at 181–500 days p/s, r
2=0.516, p=0.039. Thus we
found only sporadic associations between levels of HIV-1 RNA
load and intra-patient viral diversity within non-structural genes.
This can be attributed to the relatively short region of analyzed
viral genes, fewer timepoints analyzed, uneven number of
generated quasispecies, or missing the region encoding the second
exons for Tat and Rev.
The potential difference in intra-patient diversity within HIV-
1C non-structural genes between extended high viremics [21] and
other patients during primary HIV-1C infection were also
examined. Levels of intra-patient diversity between these two
HIV-1C Viral Diversity and Diversification
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91–180, and 181–500 days p/s. We hypothesized a higher level of
viral diversity within the HIV-1C non-structural genes in extended
high viremics; however, no significant differences between groups
were found (Fig. S3).
Discussion
This study performed a comprehensive analysis of the molecular
evolution of HIV-1C non-structural genes during primary in-
fection from seroconversion up to 500 days p/s. To our best
knowledge, this is the first report on the extent and dynamics of
viral diversity within HIV-1C non-structural genes during primary
HIV-1C infection. Also recent studies suggest that HIV-1C
infections may show unusually high HIV RNA levels for
prolonged periods following initial infection.
A limited number of studies have addressed viral quasispecies in
HIV-1C infection [33–35], although none has focused on the
evolution of HIV-1C non-structural genes. While the diversity of
HIV-1C non-structural genes has been addressed in previous
cross-sectional studies [36–38], these studies were not powered to
evaluate the extent of viral diversification over time. The use of the
SGA method in this study allowed the assessment of longitudinal
Figure 1. HIV-1 subtyping by analysis of phylogenetic relationships of HIV-1 non-structural genes. The analyzed region of HIV-1
genome corresponded to nucleotide positions 5,041 to 6,310 in HXB2. Three sequences were randomly selected for each study subject (see
Methods). A phylogenetic tree was inferred by Mr. Bayes using GTR model. The convergence was reached after 10 M MCMC run. The consensus tree
was visualized in Figtree v.1.3.1 [54]. Clade credibility values of .0.95 shown by asterisk, Subtype D cluster showed the support of 0.93 indicated by +
symbol. HIV-1 subtype C reference sequences are shown as blue circles. All non-subtype C group M reference sequences are shown at the bottom of
the phylogenetic tree. SIV sequence (CPZ.CM98.CAM3.AF115393) was used as an outgroup.
doi:10.1371/journal.pone.0035491.g001
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primary HIV-1C infection.
Intra-patient nucleotide diversity increased over time in all
non-structural genes studied, which is consistent with previously
published data on env gp120 in primary HIV-1B [8] and HIV-
1C [23] infection. The tight range observed in vif (0%–0.51%),
vpr (0%–0.58%), vpu (0–1.98%), tat1 (0%–0.86%) and rev1 (0%–
1.33%) at the earliest timepoint which increased slightly up to
500 days p/s vif (0%–1.11%),vpr (0%–1.30%),vpu (0.28%–
2.35%), tat exon1 (0%–1.66%) and rev exon1 (0%–1.57%)
highlights the high level of viral conservation in HIV-1 non-
structural genes. Viral diversification in non-structural genes is
lower than in structural HIV-1 genes, which is evident from
comparison of slopes with the slope in HIV-1 Benv reported at
1% per year [8]. Previous studies have assessed whether viral
mutations occur within CTL epitopes and/or flanking regions;
however, most previous studies analyzed primarily structural
viral genes, and evolution of CTL epitopes within accessory
genes remains understudied [1,39–44]. Therefore, it remains
unclear to what extent selection pressure drives evolution of the
HIV-1 non-structural genes. Although data from cross-sectional
HIV-1C studies have shown a high level of conservation in
major non-structural genes [36–38].The lower level of non-
structural genes diversity during the primary infection is
consistent with known viral homogeneity during this period
[23,45–48].
Figure 2. HIV-1 subtype C phylogenetic relationship and diversity of HIV non-structural genes is consistent with the multiplicity of
HIV-1 infection determined by analysis of the env/gag genes. A maximum likelihood phylogenetic tree was reconstructed using Fastree2
(Price et al., 2010) using the GTR+G model for nucleotide substitution and visualized in Figtree v.1.1.3 [54]. Alternative likelihood ratio tests [55] .0.95
are shown by an asterisk. Subjects infected with multiple viral variants are colored red. Patient B and D subtrees (individual trees on grey background)
show branching topology of earliest sampling (0–90 days p/s) and represent examples of single (subject B) and multiple (subject D) HIV-1
transmission.
doi:10.1371/journal.pone.0035491.g002
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structural viral genes can be used reliably for HIV-1 subtyping,
which is consistent with previous studies [36,49–51]. The sporadic
associations between non-structural HIV-1C gene diversity and
viral RNA load in plasma is consistent with previous studies
[4,52,53]. The viral diversity in HIV-1C non-structural genes was
consistent with multiplicity of viral transmission and results in the
env/gag analysis [32]. The analyzed timepoints allowed us to detect
transmission of more than a single viral variant. However, we were
not able to deduce the number of transmitted viral variants due to
potential recombinations between transmitted variants, if samples
were collected later than Fiebig stage IV.
The relatively small sample size and different number of
generated viral quasispecies per timepoint and/or per subject are
the major limitations in this study. Ideally, it would have been
preferable to obtain at least 20 sequences for each patient at each
timepoint. However, this task was challenging and difficult to
achieve due to inter-subject heterogeneity and viral RNA as
a template for amplification. An additional limitation of the study
is the overlapping nature of the proteins in the region amplified,
making it difficult to assign specific mutational events to specific
proteins. Also, the second exon of tat and rev were not studied.
The study provides insights into the dynamics of the non-
structural HIV-1C genes during the early stages of infection.
The results of our study highlight differential diversity across
HIV-1 genes and slower diversification of viral accessory genes
over time. Apparently, the most likely reason is different
selection pressure imposed by host immune response to the
encoded viral gene products which may result in different
evolutionary rates. Our results suggest (1) a high level of
conservation of viral non-structural genes during primary HIV-
1C infection; (2) a gradual increase in viral diversity of these
genes over the first 500 days p/s; and (3) no associations
between levels of viral diversity within the non-structural genes
and HIV-1 RNA load during primary infection, which might be
due to a relatively small sample size. To conclusively evaluate
potential associations, larger and more in-depth studies might be
warranted. This could yield valuable information to aid vaccine
development, due to the increasing interest of non-structural
genes as targets in vaccine design.
Supporting Information
Figure S1 HIV-1 subtyping. Phylogenetic relationship between
HIV-1 non-structural genes. A phylogenetic tree was constructed
using PhyML [49] using the GTR+I+G model for nucleotide
substitution and visualized in Mega 5 [27]. Three sequences were
used for each patient Subjects’ branches are labeled on the right
with patient codes. aLRT .0.99 shown by asterisk. HIV-1
subtype C reference sequences are shown in blue, and all other
HIV-1 group M (non-C) reference sequences are labeled at the
bottom of the figure. SIV sequence (CPZ CM98.CA-
M3.AF115393) was used to root the tree.
(TIF)
Figure S2 HIV-1 subtyping. Phylogenetic relationship between
HIV-1 non-structural genes. A phylogenetic tree was constructed
from nucleotide alignments using Neighbor Joining (NJ) method.
The evolutionary distances were computed using the Kimura 2-
parameter method. The reliability of the branching topology was
estimated from 1000 bootstrap replicates. Patient identifiers are
shown to the right of the tree. Bootstrap values .99% are
indicated by asterisks. SIV sequence (CPZ CM98 CAM3
AF115393) was used to root the tree.
(TIF)
Figure S3 Viremics Analysis; Kimura 2-parameter overall mean
pairwise diversity of HIV-1C non-structural genes vif, vpr, vpu, tat
exon1 and rev exon1 comparing two groups (high viremics –
Figure 3. Individual distribution of pairwise distances for each of the non-stuctural genes,vif (HXB2 start 5041 to 5619), vpr (HXB2
start 5559 to 5850), vpu (HXB2 start 6062 to 6310), tat exon 1 (HXB2 start 5831 to 6045), and rev exon 1(HXB2 start 5970 to 6045).
doi:10.1371/journal.pone.0035491.g003
Figure 4. HIV-1C diversity, mean and 95% confidence intervals
for non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1
over the first 500 days p/s. Viral diversity for each subject was
calculated using maximum composite likelihood model [56].
doi:10.1371/journal.pone.0035491.g004
HIV-1C Viral Diversity and Diversification
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(TIF)
Table S1 Subject demographics, time points of sampling, HIV-1
RNA load, CD4 count, and Fiebig stage at enrollment.
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